What LSD Is
Lysergic acid diethylamide was first synthesised by Swiss chemist Albert Hofmann at Sandoz Pharmaceuticals in 1938, and its psychoactive properties were discovered accidentally on April 19, 1943 — a date now commemorated as "Bicycle Day." Hofmann, experiencing the effects of accidental skin absorption, cycled home from his laboratory and carefully documented the world's first intentional LSD experience the following day.
LSD is a semi-synthetic compound derived from ergotamine, an alkaloid produced by the ergot fungus (Claviceps purpurea). It is not found in nature in its synthesised form — distinguishing it from the naturally occurring tryptamine psychedelics (psilocybin, DMT, mescaline) that are the primary focus of the Psygaia Framework. This distinction is pharmacologically meaningful: LSD has a longer duration, a more stimulating character, and subtly different phenomenological qualities than classical plant-based tryptamines.
LSD is active at doses measured in micrograms (millionths of a gram) — making it one of the most potent psychoactive substances known. A standard recreational dose is 75–150 micrograms; doses above 200 micrograms are considered high, and the dose-response relationship is steep.
Pharmacology
Like psilocybin and DMT, LSD acts primarily as a serotonin 5-HT2A receptor agonist. However, LSD has a broader receptor binding profile — it also binds with high affinity at dopamine D2, adrenergic, and other serotonin receptor subtypes, which accounts for its more stimulating, energising character compared to psilocybin.
A distinctive pharmacological feature of LSD is its "kinetic trapping" at the receptor: an LSD molecule, once bound to the 5-HT2A receptor, is covered by a "lid" formed by a loop of the receptor protein and is released very slowly — a mechanism discovered by Wacker and colleagues (2017) that explains LSD's uniquely long duration of action compared to other tryptamines.
Effects
Onset (30–90 minutes)
Gradual onset with early signs: tingling, alertness, mild perceptual brightening, slight anxiety or anticipation. The onset is slower than psilocybin and less characterised by the body weight and warmth sensations common in mushroom experiences.
Ascent and peak (3–6 hours)
LSD's peak is broad and extended rather than sharp. Perceptual effects are prominent: visual patterns and tracers are typically more crisp and geometric than psilocybin. Thought acceleration and a stimulant-like quality are characteristic. LSD is more cognitively activating — many people find it more difficult to rest or surrender during an LSD experience than a mushroom one.
Plateau and long tail (6–10+ hours)
LSD's total duration — 8–12 hours, sometimes longer — is its most significant practical distinction from psilocybin. The extended plateau means the experience demands more physical and psychological endurance. Sleep is typically impossible for 10–14 hours after a moderate dose. Planning accordingly — ensuring the following day is unencumbered — is essential.
Afterglow
A clear, reflective quality often persists for 12–24 hours. Some people find this afterglow more productive for integration than psilocybin's — others find the residual stimulation disruptive.
Dosage Reference
LSD doses are measured in micrograms (μg). Street tabs of unknown origin are notoriously variable — testing is essential. See the testing section below.
| Level | Dose (μg) | Character | Duration |
|---|---|---|---|
| Microdose | 5–20 μg | Sub-perceptual; mood and focus | 8–12 hrs (subtle) |
| Low / Threshold | 25–50 μg | Mild perceptual shifts; manageable | 8–10 hrs |
| Moderate | 75–125 μg | Clear psychedelic experience | 8–12 hrs |
| High | 150–250 μg | Intense; likely ego dissolution | 10–14 hrs |
| Very high | 250+ μg | Extreme; not recommended without experience | 12–16 hrs |
Because LSD is active at such small amounts, precise dosing from blotter paper is nearly impossible. Volumetric dosing — dissolving a known quantity of LSD in a measured volume of distilled water and dosing by volume — is the most reliable way to achieve consistent doses at the microdosing and low-dose range. One tab dissolved in 10 mL of water = 1 mL per tenth of a tab.
LSD vs. Psilocybin: Key Differences
Duration. LSD: 8–12 hours. Psilocybin: 4–6 hours. This is the single most important practical difference. LSD demands greater stamina and more careful scheduling.
Character. LSD tends to be more stimulating, cerebral, and visually crisp. Psilocybin tends to be warmer, more emotionally directive, and more body-centred. LSD is less likely to produce the surrender and dissolution that characterises the deepest mushroom experiences — though at high doses, the distinction diminishes.
Ecological phenomenology. Both substances produce ecological and relational themes, though psilocybin produces them more consistently and with greater emotional intensity in the empirical literature. LSD's cognitive activation may actually make ecological attunement more difficult to access at moderate doses.
Clinical research. Psilocybin has a substantially larger and more recent clinical evidence base. LSD research was effectively frozen from the early 1970s until recent years — though studies at Imperial College and in Switzerland have resumed.
Research on LSD
LSD was the first psychedelic to attract serious psychiatric research, beginning in the 1950s. Sandoz distributed LSD to researchers under the name Delysid throughout the 1950s and early 1960s, producing over 1,000 published papers before prohibition halted research.
Contemporary research has resumed cautiously. Liechti and colleagues in Basel have published pharmacological and dose-finding studies. Imperial College London's work under David Nutt and Robin Carhart-Harris has included LSD in neuroimaging and comparative studies. Research specifically on LSD-assisted psychotherapy is less advanced than psilocybin research, but the pharmacological similarities suggest therapeutic mechanisms are broadly comparable.
Risks and Harm Reduction
LSD shares the key interaction profile of classical psychedelics — SSRIs, MAOIs, lithium, and stimulants all carry meaningful risks. View full drug interaction chart →
Adulteration. Street LSD is frequently misdosed, and some tabs sold as LSD contain NBOMe compounds or other substances. Testing is not optional — see below.
Duration-related risks. The extended duration means that a difficult experience lasts significantly longer than with psilocybin. Having an experienced sitter is especially valuable for first experiences.
HPPD. Hallucinogen Persisting Perception Disorder — persistent visual disturbances after the experience has ended — is rare but real. Risk appears to be dose-related and elevated in people with pre-existing anxiety disorders.
Cardiovascular. LSD produces moderate increases in heart rate and blood pressure. Cardiac contraindications apply.
Psychological contraindications mirror psilocybin: personal or family history of schizophrenia spectrum disorders or bipolar I is a firm contraindication.
Testing Your Supply
Testing LSD is non-negotiable. The Ehrlich reagent turns purple in the presence of indole alkaloids — a positive result indicates an LSD-type compound is present. The Hofmann reagent is more specific for LSD. Crucially, neither test rules out the presence of additional substances.
The most reliable testing method is fentanyl test strips (for the ever-present contamination risk) combined with an Ehrlich reagent. Test kits are available from DanceSafe. In Canada, drug checking services in several cities offer more precise analysis.